Edwards Lifesciences (EW) SEC Filings: History & Chart

Edwards Lifesciences Corporation (EW)EWEdwards Lifesciences Corporation

About Edwards Lifesciences Corporation

Edwards Lifesciences Corporation is a global medical technology firm specializing in sophisticated products and technologies for structural heart conditions, alongside critical care and surgical patient monitoring. With operations spanning the United States, Europe, Japan, and various international territories, the company offers a comprehensive suite of solutions. Their structural heart disease portfolio encompasses transcatheter heart valve replacement systems designed for minimally invasive procedures, as well as transcatheter repair and replacement options specifically targeting mitral and tricuspid valve pathologies, exemplified by their PASCAL and Cardioband systems. Additionally, they provide advanced surgical structural heart solutions, including the INSPIRIS aortic surgical valve, the KONECT RESILIA pre-assembled aortic tissue valved conduit for complex valve, root, and ascending aorta replacements, and the HARPOON Beating Heart Mitral Valve Repair System for patients suffering from degenerative mitral regurgitation. In the realm of critical care, Edwards supplies advanced hemodynamic monitoring systems that assess patients' cardiac function and fluid status in both surgical and intensive care environments. This offering also features the Acumen Hypotension Prediction Index software, which provides early alerts to clinicians regarding potential dangerously low blood pressure. The company distributes its products to healthcare providers through a combination of its proprietary sales force and independent distributor networks. Founded in 1958, Edwards Lifesciences Corporation maintains its headquarters in Irvine, California.

Irvine, CA

16,000 employees

www.edwards.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Bernard J. Zovighian

View full financials

Form	Filing Date	Accepted	Document
4	Aug 11, 2026	Aug 11, 2026	View filing
S-8	Aug 4, 2026	Aug 4, 2026	View filing
10-Q	Aug 4, 2026	Aug 4, 2026	View filing
4	Jul 30, 2026	Jul 30, 2026	View filing
4	Jul 28, 2026	Jul 28, 2026	View filing
4	Jul 27, 2026	Jul 27, 2026	View filing
8-K	Jul 23, 2026	Jul 23, 2026	View filing
4	Jul 13, 2026	Jul 13, 2026	View filing
4	Jul 10, 2026	Jul 10, 2026	View filing
4	Jul 10, 2026	Jul 10, 2026	View filing
4	Jul 7, 2026	Jul 7, 2026	View filing
4	Jun 30, 2026	Jun 30, 2026	View filing
4	Jun 17, 2026	Jun 17, 2026	View filing
11-K	Jun 12, 2026	Jun 12, 2026	View filing
11-K	Jun 12, 2026	Jun 12, 2026	View filing
3	Jun 1, 2026	Jun 1, 2026	View filing
4	May 29, 2026	May 29, 2026	View filing
4	May 27, 2026	May 27, 2026	View filing
SD	May 27, 2026	May 27, 2026	View filing
4	May 22, 2026	May 22, 2026	View filing
4	May 18, 2026	May 18, 2026	View filing
4	May 18, 2026	May 18, 2026	View filing
4	May 12, 2026	May 12, 2026	View filing
4	May 12, 2026	May 12, 2026	View filing
4	May 12, 2026	May 12, 2026	View filing
4	May 11, 2026	May 11, 2026	View filing
4	May 11, 2026	May 11, 2026	View filing
4	May 11, 2026	May 11, 2026	View filing
4	May 11, 2026	May 11, 2026	View filing
4	May 8, 2026	May 8, 2026	View filing

SEC Filings

Recent Filings